Recipharm's New ReciPredict Platform To Speed Up Drug Development

Recipharm has introduced ReciPredict, an innovative platform that applies Quality by Design (QbD) principles to revolutionize drug product development, technology transfer, and manufacturing processes. By integrating material science with statistical analysis, along with modeling and simulation techniques, ReciPredict is set to enhance efficiency and ensure greater reliability. This platform simplifies the entire product development journey, from early formulation stages to full-scale manufacturing.

Dr. Uwe Hanenberg, PhD, Head of Product Implementation, said in a statement, “ReciPredict accelerates the journey of new drugs to the clinical stage by 3-6 months, substantially expediting the drug development process. It also offers significant cost savings by reducing API consumption by 30% to 70%. Another crucial advantage is that applying ReciPredict de-risks tech transfers by identifying the right parameters for best process robustness, consequently achieving consistent and high-quality results. This is a win-win for our customers and for patients, as it helps bring new drugs to market faster.”

Hanenberg further added,“ReciPredict offers an unparalleled understanding of materials and processes, enabling faster and more efficient drug development. As such, it provides great efficiencies by solving complex problems in product development, tech transfers, and routine manufacturing. Our key capabilities include an expert data science and statistics team, advanced modeling tools, comprehensive statistical tools, powder characterization (FT4, Accupyc, BET, and more), and a Style One Evo compression and compaction simulator. These features collectively ensure that ReciPredict stands out as a robust and reliable platform in the pharmaceutical industry.”

ReciPredict utilizes cutting-edge data science and statistical techniques, integrating sophisticated models and tools to link critical process parameters, material characteristics, and drug product quality. This in-depth analysis supports Quality by Design by providing accurate forecasts of quality outcomes based on both material properties and production conditions.

ReciPredict is a flexible tool that can be applied throughout different phases of drug development and manufacturing, such as product development, trial design, Design of Experiments (DoE), data analysis, In Silico formulation, technology transfer, and optimization of processes and formulations. Its versatility allows it to be used across various locations, products, and technologies, making it an ideal solution for pharmaceutical companies aiming to improve their development and manufacturing efficiency.